Our study is the first to identify roles for CCDC103 within the cytoplasm, independent of motile cilia, and to illuminate a mechanism underlying unexplained functional defects in PCD patient myeloid cells, which may open new avenues to improve outcomes for these patients. Here, DNAAF19 is linked to primary ciliary dyskinesia.